Brief: Aslan Pharmaceuticals Files Preliminary Prospectus Related To Offering ADS
31/05/2019 12:04
May 31 (Reuters) - Aslan Pharmaceuticals Ltd 6497.TWO :
* ASLAN PHARMACEUTICALS LTD FILES PRELIMINARY PROSPECTUS
RELATED
TO OFFERING OF UP TO $15 MILLION AMERICAN DEPOSITARY SHARES -
SEC FILING
Source text: (http://bit.ly/2YWVrcH)
Further company coverage: 6497.TWO
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Aslan Pharmaceuticals
See all newsBrief: Aslan Pharmaceuticals Announces Plan To Implement ADS Ratio Change
Brief: Aslan Pharmaceuticals Ltd Files For Shelf Of Up To 61.9 Million Ordinary Shares By Selling Stockholder - SEC Filing
Brief: Aslan Pharmaceuticals Announces Expansion Of Its Collaboration With Zenyaku
Brief: Aslan Pharmaceuticals Announces Positive Interim Results From Phase 2 Study Of Eblasakimab
Brief: ASLAN Pharmaceuticals To Sell ADSs Having An Aggregate Offering Price Of Up To $12 Mln